Commerzbank Aktiengesellschaft FI boosted its position in Monsanto Company (NYSE:MON) by 15.7% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 42,980 shares of the basic materials company’s stock after purchasing an additional 5,821 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Monsanto were worth $5,150,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. Meyer Handelman Co. lifted its position in Monsanto by 0.6% in the 3rd quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock valued at $14,923,000 after purchasing an additional 706 shares during the last quarter. Toronto Dominion Bank raised its position in shares of Monsanto by 6.3% during the 3rd quarter. Toronto Dominion Bank now owns 1,014,313 shares of the basic materials company’s stock worth $121,519,000 after buying an additional 59,750 shares in the last quarter. Nikko Asset Management Americas Inc. raised its position in shares of Monsanto by 1.3% during the 2nd quarter. Nikko Asset Management Americas Inc. now owns 450,700 shares of the basic materials company’s stock worth $53,345,000 after buying an additional 5,700 shares in the last quarter. Oakbrook Investments LLC raised its position in shares of Monsanto by 7.4% during the 3rd quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock worth $2,438,000 after buying an additional 1,400 shares in the last quarter. Finally, Aviva PLC raised its position in shares of Monsanto by 1.2% during the 2nd quarter. Aviva PLC now owns 304,501 shares of the basic materials company’s stock worth $36,052,000 after buying an additional 3,569 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.
MON has been the topic of a number of recent analyst reports. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Tuesday, September 5th. BMO Capital Markets restated a “buy” rating and set a $128.00 price target on shares of Monsanto in a research report on Friday, September 1st. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Barclays restated an “equal weight” rating and set a $124.00 price target (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Finally, Macquarie downgraded shares of Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of $124.61.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The company had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The business’s revenue was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.07 EPS. equities research analysts forecast that Monsanto Company will post 5.74 earnings per share for the current fiscal year.
In other news, COO Brett D. Begemann sold 22,640 shares of Monsanto stock in a transaction that occurred on Monday, September 25th. The shares were sold at an average price of $120.03, for a total value of $2,717,479.20. Following the transaction, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at $10,255,243.17. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the transaction, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The disclosure for this sale can be found here. Insiders sold a total of 49,236 shares of company stock worth $5,931,934 in the last ninety days. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.